The Anti‐platelet Effect of Aspirin in Patients with End Stage Renal Disease
Faheem O, Shah A, Haider J, Schumacher J, Liang T, Azrin M, Bellumkonda L, Walsh S, Kaplan A, Liang B. The Anti‐platelet Effect of Aspirin in Patients with End Stage Renal Disease. The FASEB Journal 2006, 20: a1139-a1139. DOI: 10.1096/fasebj.20.5.a1139.Peer-Reviewed Original ResearchAnti-platelet effectsRenal failurePlatelet aggregationControl patientsArachidonic acidEnd-stage renal diseaseAnti-platelet responseGreater platelet aggregationStage renal diseaseAgonist-induced platelet aggregationRenal failure patientsASA ingestionASA resistanceAspirin resistanceVascular eventsFailure patientsRenal diseaseControl subjectsPatientsPlatelet agonistsWhole bloodAgonistsASAVariable responseSubjects